These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38407166)

  • 1. Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection.
    Vu QM; Fitzpatrick AL; Cope JR; Bertolli J; Sotoodehnia N; West TE; Gentile N; Unger ER
    Emerg Infect Dis; 2024 Mar; 30(3):539-547. PubMed ID: 38407166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long COVID in pediatrics-epidemiology, diagnosis, and management.
    Toepfner N; Brinkmann F; Augustin S; Stojanov S; Behrends U
    Eur J Pediatr; 2024 Apr; 183(4):1543-1553. PubMed ID: 38279014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
    Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
    BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After SARS-CoV-2 Infection.
    Unger ER; Lin JS; Wisk LE; Yu H; L'Hommedieu M; Lavretsky H; Montoy JCC; Gottlieb MA; Rising KL; Gentile NL; Santangelo M; Venkatesh AK; Rodriguez RM; Hill MJ; Geyer RE; Kean ER; Saydah S; McDonald SA; Huebinger R; Idris AH; Dorney J; Hota B; Spatz ES; Stephens KA; Weinstein RA; Elmore JG;
    JAMA Netw Open; 2024 Jul; 7(7):e2423555. PubMed ID: 39046739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
    Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
    Front Immunol; 2022; 13():949787. PubMed ID: 36341457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.
    Komaroff AL; Lipkin WI
    Trends Mol Med; 2021 Sep; 27(9):895-906. PubMed ID: 34175230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
    J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
    Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
    JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
    Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
    J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 on myalgic encephalomyelitis/chronic fatigue syndrome-like illness prevalence: A cross-sectional survey.
    Wood MS; Halmer N; Bertolli J; Amsden LB; Nugent JR; Lin JS; Rothrock G; Nadle J; Chai SJ; Cope JR; Champsi JH; Yang J; Unger ER; Skarbinski J;
    PLoS One; 2024; 19(9):e0309810. PubMed ID: 39292671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Campen CLMCV; Rowe PC; Visser FC
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
    Retornaz F; Rebaudet S; Stavris C; Jammes Y
    J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not?
    Joseph P; Singh I; Oliveira R; Capone CA; Mullen MP; Cook DB; Stovall MC; Squires J; Madsen K; Waxman AB; Systrom DM
    Chest; 2023 Sep; 164(3):717-726. PubMed ID: 37054777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A technology-enabled multi-disciplinary team-based care model for the management of Long COVID and other fatiguing illnesses within a federally qualified health center: protocol for a two-arm, single-blind, pragmatic, quality improvement professional cluster randomized controlled trial.
    Godino JG; Samaniego JC; Sharp SP; Taren D; Zuber A; Armistad AJ; Dezan AM; Leyba AJ; Friedly JL; Bunnell AE; Matthews E; Miller MJ; Unger ER; Bertolli J; Hinckley A; Lin JS; Scott JD; Struminger BB; Ramers C
    Trials; 2023 Aug; 24(1):524. PubMed ID: 37573421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
    BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
    Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
    Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.
    Nunes JM; Kell DB; Pretorius E
    Blood Rev; 2023 Jul; 60():101075. PubMed ID: 36963989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient who recovered from post-COVID myalgic encephalomyelitis/chronic fatigue syndrome: a case report.
    Oka T
    Biopsychosoc Med; 2023 Feb; 17(1):8. PubMed ID: 36855180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.